HPV-associated and HPV-attributable cancers — Nearly 50,000 HPV-associated cancers are diagnosed in the United States each year. CDC estimates that HPV causes roughly 39,000 cancers annually.
Sources: CDC — Cancers Associated with Human Papillomavirus · Van Dyne et al., Frontiers in Public Health (2021), pmc.ncbi.nlm.nih.gov/articles/PMC7921151
​
HPV vaccination and prevention of HPV-attributable cancers
Source: CDC — Cancers Associated with Human Papillomavirus
​
Throat cancer overtaking cervical cancer — More than 21,000 throat cancer cases a year, versus roughly 12,000 for cervical.
Sources: UCI Health, citing CDC · CDC MMWR
​
Racial disparity in cervical cancer mortality — Black women are 1.5 times more likely to die from cervical cancer than white women.
Source: U.S. Preventive Services Task Force (2024)
​
Screening and follow-up disparities by race
Sources: Cancer Health Disparities (2022), sciencedirect.com · American Journal of Preventive Medicine (2023), ajpmonline.org
​
Lifetime HPV infection and clearance rates — 91% of men, 85% of women get HPV; about 90% clear on their own.
Source: CDC — Clinical Overview of HPV
​
No FDA-approved test to determine a man's overall HPV status
Source: CDC Pink Book, Chapter 11
​
HPV vaccination for adults ages 27–45 — CDC recommends shared clinical decision-making for some adults who were not adequately vaccinated.
Source: CDC ACIP — Shared Clinical Decision-Making
​
HPV vaccination after prior exposure — Vaccination prevents new HPV infections and does not treat an existing infection, but a person previously exposed to HPV may not have been exposed to every vaccine-targeted type.
Sources: CDC · Mayo Clinic · CHOP
​
​